GOSSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Gossamer Bio, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$8.43−0.34 (-3.88%)
Close on Oct 19, 2026
- Market cap
- $2.77B
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Gossamer Bio's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 25, 2026 | Sep 28, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 23, 2026 | Sep 23, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Oct 27, 2026 | Sep 16, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 16, 2026 | Sep 16, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 10, 2026 | Sep 11, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 9, 2026 | Sep 9, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 3, 2026 | Sep 3, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 24, 2026 | Aug 26, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 20, 2026 | Aug 21, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2026 | Aug 13, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 23, 2026 | Jul 27, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 14, 2026 | Jul 15, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 1, 2026 | Jul 1, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2026 | Jun 17, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jul 14, 2026 | Jun 9, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 3, 2026 | Jun 5, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2026 | Jun 5, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 2, 2026 | Jun 2, 2026 | SEC EDGAR |
| Current report | 8-K | May 18, 2026 | May 18, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 15, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 24, 2026 | Apr 24, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 8, 2026 | Apr 9, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 17, 2026 | Mar 17, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 17, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 23, 2026 | Feb 23, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 5, 2025 | Nov 5, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 5, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 24, 2025 | Sep 25, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2025 | Aug 5, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 5, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 25, 2025 | Jun 25, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 16, 2025 | Jun 16, 2025 | SEC EDGAR |
| Current report | 8-K | May 15, 2025 | May 15, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 15, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 28, 2025 | Apr 29, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 13, 2025 | Mar 13, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 13, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 19, 2025 | Feb 19, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2024 | Nov 7, 2024 | SEC EDGAR |